Prime Medicine Inc (PRME)
3.345
-0.25
(-6.95%)
USD |
NASDAQ |
Nov 15, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Profit Margin (Quarterly): -25.13K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -25.13K% |
| June 30, 2024 |
| Date | Value |
|---|---|
| March 31, 2024 | -7.74K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-25.13K%
Minimum
Sep 2024
-7.74K%
Maximum
Mar 2024
-16.44K%
Average
-16.44K%
Median
Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 10.18% |
| Molecular Templates Inc | -4.28K% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
| IGC Pharma Inc | -874.3% |
Profit Margin (Quarterly) Related Metrics
| Operating Margin (Quarterly) | -25.95K% |